The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome

Summary Background There is evidence that a T‐helper (Th) 2 cytokine pattern dominates in the peripheral blood as well as in tissue of patients with Sézary syndrome (SS), and that the malignant clone is of Th2 phenotype. However, there are conflicting studies on the cytokine pattern in the periphera...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of dermatology (1951) 2003-04, Vol.148 (4), p.709-718
Hauptverfasser: Papadavid, E., Economidou, J., Psarra, A., Kapsimali, V., Mantzana, V., Antoniou, C., Limas, K., Stratigos, A., Stavrianeas, N., Avgerinou, G., Katsambas, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Background There is evidence that a T‐helper (Th) 2 cytokine pattern dominates in the peripheral blood as well as in tissue of patients with Sézary syndrome (SS), and that the malignant clone is of Th2 phenotype. However, there are conflicting studies on the cytokine pattern in the peripheral blood in different stages of cutaneous T‐cell lymphoma (CTCL). Objectives To examine, by means of flow cytometry (FC), the Th1/Th2 cytokine profile [cytoplasmic interferon (IFN)‐γ/interleukin (IL)‐4] in peripheral blood T cells from patients with mycosis fungoides (MF) and SS, the most common forms of CTCL, and to correlate their expression with clinical stage, clonality and T‐cell immunophenotype changes in order to evaluate their relevance in CTCL progression. Methods We investigated by FC the percentage of CD3+ T cells expressing cytoplasmic IFN‐γ and IL‐4 after stimulation in blood specimens of 43 CTCL patients (32 stage I–II and 11 stage III–IV), eight of whom were erythrodermic. Next, we compared cytoplasmic IFN‐γ and IL‐4 expression between patients of different stages and controls, and correlated our findings to T‐cell receptor (TCR)‐γ gene rearrangement, used as a marker of clonality, and changes in T‐cell immunophenotype (CD4+, CD8+, CD4+/CD7–, CD4+/CD25+) and natural killer cells. Polymerase chain reaction amplification of the TCR‐γ gene was performed in 41 blood and 26 skin specimens. We also examined the cytokine expression pattern in patients with erythrodermic MF and SS. Results A significantly higher frequency of CD3+/IL‐4+ T cells was found in late (III–IV) compared with early (I–II) CTCL patients (P = 0·002) or controls (P 
ISSN:0007-0963
1365-2133
DOI:10.1046/j.1365-2133.2003.05224.x